年別の研究成果
年別の研究成果
- 29 件
検索結果
-
2024
Current status and future perspective of immunotherapy for renal cell carcinoma
Blas, L., Monji, K., Mutaguchi, J., Kobayashi, S., Goto, S., Matsumoto, T., Shiota, M., Inokuchi, J. & Eto, M., 8月 2024, In: International Journal of Clinical Oncology. 29, 8, p. 1105-1114 10 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
3 被引用数 (Scopus) -
Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer
Shiota, M., Endo, S., Tsukahara, S., Tanegashima, T., Kobayashi, S., Matsumoto, T. & Eto, M., 2024, In: Endocrine-Related Cancer. 31, 7, e240023.研究成果: ジャーナルへの寄稿 › 総説 › 査読
3 被引用数 (Scopus) -
2023
Steroidogenesis in castration-resistant prostate cancer
Shiota, M., Endo, S., Blas, L., Fujimoto, N. & Eto, M., 5月 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 5, p. 240-251 12 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access11 被引用数 (Scopus) -
2022
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
Blas, L., Shiota, M. & Eto, M., 9月 2022, In: Cancers. 14, 17, 4161.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access7 被引用数 (Scopus) -
Androgen receptor mutations for precision medicine in prostate cancer
Eto, M., Shiota, M., Akamatsu, S., Tsukahara, S., Nagakawa, S. & Matsumoto, T., 10月 2022, In: Endocrine-Related Cancer. 29, 10, p. R143-R155研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access39 被引用数 (Scopus) -
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy
Shiota, M., Blas, L. & Eto, M., 6月 1 2022, In: Cancers. 14, 11, 2696.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access14 被引用数 (Scopus) -
Current status and future perspective on the management of metastatic castration-sensitive prostate cancer
Blas, L., Shiota, M. & Eto, M., 1月 2022, In: Cancer Treatment and Research Communications. 32, 100606.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access14 被引用数 (Scopus) -
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
Matsumoto, T., Shiota, M., Blas, L. & Eto, M., 2022, In: Cancer Management and Research. 14, p. 2389-2397 9 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access2 被引用数 (Scopus) -
2021
Current status and future perspectives of immunotherapy against urothelial and kidney cancer
Kobayashi, T., Takeuchi, A., Nishiyama, H. & Eto, M., 10月 1 2021, In: Japanese journal of clinical oncology. 51, 10, p. 1481-1492 12 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access7 被引用数 (Scopus) -
Efficacy of intranodal neoantigen peptide-pulsed dendritic cell vaccine monotherapy in patients with advanced solid tumors: A retrospective analysis
MORISAKI, T., MORISAKI, T., KUBO, M., ONISHI, H., HIRANO, T., MORISAKI, S., ETO, M., MONJI, K., TAKEUCHI, A., NAKAGAWA, S., TANAKA, H., KOYA, N., UMEBAYASHI, M., TSUJIMURA, K., YEW, P. Y., YOSHIMURA, S., KIYOTANI, K. & NAKAMURA, Y., 8月 2021, In: Anticancer research. 41, 8, p. 4101-4115 15 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access9 被引用数 (Scopus) -
Treatment of metastatic castration-resistant prostate cancer: Are PARP inhibitors shifting the paradigm?
Fujimoto, N., Harada, K., Shiota, M., Tomisaki, I., Minato, A., Nagata, Y., Kimuro, R., Harada, M. & Fujisawa, M., 10月 2021, In: Anticancer research. 41, 10, p. 4687-4695 9 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access3 被引用数 (Scopus) -
Treatment strategies for metastatic castration-sensitive prostate cancer: From “all-comers” to “personalized” approach
Harada, K., Shiota, M., Minato, A., Matsumoto, M., Tomisaki, I., Fujisawa, M. & Fujimoto, N., 2021, In: OncoTargets and Therapy. 14, p. 2967-2974 8 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access14 被引用数 (Scopus) -
2020
Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application
Kato, K., Takeuchi, A., Akashi, K. & Eto, M., 1月 31 2020, In: Frontiers in Immunology. 10, 3138.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access8 被引用数 (Scopus) -
2019
Reconsideration on clinical benefit of pelvic lymph node dissection during radical prostatectomy for clinically localized prostate cancer
Fujimoto, N., Shiota, M., Tomisaki, I., Minato, A. & Yahara, K., 8月 1 2019, In: Urologia Internationalis. 103, 2, p. 125-136 12 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access28 被引用数 (Scopus) -
The role of nuclear receptors in prostate cancer
Shiota, M., Fujimoto, N., Kashiwagi, E. & Eto, M., 2019, In: Cells. 8, 6, 602.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access31 被引用数 (Scopus) -
2018
Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy
Takeuchi, A., Kato, K., Akashi, K. & Eto, M., 2月 2018, In: International Journal of Urology. 25, 2, p. 112-120 9 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access9 被引用数 (Scopus) -
2017
Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer
Fujimoto, N., Shiota, M., Tomisaki, I. & Minato, A., 6月 2017, In: Clinical Genitourinary Cancer. 15, 3, p. 337-342 6 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
18 被引用数 (Scopus) -
2016
BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives
takeuchi, A., Shiota, M., Tatsugami, K., Yokomizo, A. & Eto, M., 1月 1 2016, In: Fukuoka igaku zasshi = Hukuoka acta medica. 107, 1, p. 8-11 4 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
-
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer
Shiota, M. & Eto, M., 5月 1 2016, In: International Journal of Urology. 23, 5, p. 360-369 10 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access68 被引用数 (Scopus) -
2014
EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer
Kashiwagi, E., Shiota, M., Yokomizo, A., Inokuchi, J., Uchiumi, T. & Naito, S., 3月 2014, In: Prostate Cancer and Prostatic Diseases. 17, 1, p. 10-17 8 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
24 被引用数 (Scopus) -
The concept and mechanisms of castration-resistant prostate cancer
Naito, S. & Shiota, M., 12月 1 2014, In: Nihon rinsho. Japanese journal of clinical medicine. 72, 12, p. 2090-2094 5 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
-
2013
[Urinary retention].
Takahashi, R. & Naito, S., 6月 2013, In: Unknown Journal. 71, 6, p. 1024-1026 3 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
-
Castration-resistant prostate cancer: Novel therapeutics pre- or post-taxane administration
Shiota, M., Yokomizo, A., Fujimoto, N., Kuruma, H. & Naito, S., 2013, In: Current Cancer Drug Targets. 13, 4, p. 444-459 16 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
20 被引用数 (Scopus) -
2012
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
Shiota, M., Yokomizo, A. & Naito, S., 12月 2012, In: Endocrine-Related Cancer. 19, 6, p. R243-R253研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access60 被引用数 (Scopus) -
2011
[Alteration of androgen receptor cofactor in prostate cancer].
Shiota, M., Yokomizo, A., Naito, S. & Fujimoto, N., 6月 2011, In: Nihon rinsho. Japanese journal of clinical medicine. 69 Suppl 5, p. 108-111 4 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
-
Androgen receptor cofactors in prostate cancer: Potential therapeutic targets of castration-resistant prostate cancer
Shiota, M., Yokomizo, A., Fujimoto, N. & Naito, S., 9月 2011, In: Current Cancer Drug Targets. 11, 7, p. 870-881 12 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
38 被引用数 (Scopus) -
Increased androgen receptor transcription: A cause of castration-resistant prostate cancer and a possible therapeutic target
Shiota, M., Yokomizo, A. & Naito, S., 8月 2011, In: Journal of Molecular Endocrinology. 47, 1, p. R25-R41研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access95 被引用数 (Scopus) -
2010
Immunotherapy for renal cell carcinoma
Tatsugami, K. & Itsumi, M., 2010, In: Clinical and Developmental Immunology. 2010, 284581.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access58 被引用数 (Scopus) -
Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate cancer
Fujimoto, N., Shiota, M., Kubo, T. & Matsumoto, T., 11月 2010, In: Expert Review of Clinical Pharmacology. 3, 6, p. 785-795 11 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
9 被引用数 (Scopus)